IRWD IRONWOOD PHARMACEUTICALS INC
Nasdaq · SEC CIK 1446847 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $22.50M 11 sales by 8 insiders
- Filings on record
- 207 since 2021-07-22, latest 2026-09-17 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DENNER ALEXANDER J | Dir, 10% | — | $20.53M |
| Silver Ronald | Principal Accounting Off | — | $831.2K |
| MCCOURT Thomas A | CEO, Dir | — | $739.9K |
| John Minardo | CLO | — | $136.2K |
| Gaskins Tammi L | Chief Commercial Off | — | $100.3K |
| Martini Gregory S. | CFO | — | $81.9K |
| McHugh Julie | Dir | — | $80.5K |
| Silber Jeffrey | SVP, CMO, Head-Res, Drug | — | — |
| Moukheibir Catherine | Dir | — | — |
| Duane Jon R | Dir | — | — |
Transactions 219
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:05 | 2026-09-15 | IRWD | DENNER ALEXANDER J | Dir | A - Grant | $0.00 | +3,694 | 327.5K | +1% | $0 | |
| 2026-07-22 16:10 | 2026-07-20 | IRWD | Silber Jeffrey | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +137.0K | 137.0K | New | $0 | |
| T | 2026-07-09 16:32 | 2026-07-07 | IRWD | Silver Ronald | PFO, PAO | S - Sale | $4.52 | -127.9K | 313.7K | -29% | -$578.1K |
| 2026-06-17 16:47 | 2026-06-16 | IRWD | Shepard Jay | Dir | A - Grant | $0.00 | +63.5K | 235.0K | +37% | $0 | |
| 2026-06-17 16:45 | 2026-06-16 | IRWD | Kessler Marla L | Dir | A - Grant | $0.00 | +63.5K | 229.4K | +38% | $0 | |
| 2026-06-17 16:44 | 2026-06-16 | IRWD | Currie Mark G | Dir | A - Grant | $0.00 | +63.5K | 676.9K | +10% | $0 | |
| 2026-06-17 16:43 | 2026-06-16 | IRWD | Duane Jon R | Dir | A - Grant | $0.00 | +63.5K | 253.8K | +33% | $0 | |
| M | 2026-06-17 16:42 | 2026-06-15+ | IRWD | DENNER ALEXANDER J | Dir | A - Grant | $0.00 | +67.5K | 323.9K | +26% | $0 |
| T | 2026-06-17 16:41 | 2026-06-16 | IRWD | McHugh Julie | Dir | A - Grant | $0.00 | +63.5K | 272.3K | +30% | $0 |
| T | 2026-06-17 16:41 | 2026-06-16 | IRWD | McHugh Julie | Dir | S - Sale | $3.73 | -21.6K | 250.7K | -8% | -$80.5K |
| 2026-06-17 16:36 | 2026-06-16 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +63.5K | 181.4K | +54% | $0 | |
| 2026-05-21 16:05 | 2026-05-19 | IRWD | Silver Ronald | PFO, PAO | A - Grant | $0.00 | +25.0K | 441.6K | +6% | $0 | |
| MI | 2026-03-17 | 2026-03-17 | IRWD | DENNER ALEXANDER J | Dir | S - Sale | $3.05 | -6.73M | 9.19M | -42% | -$20.53M |
| 2026-03-17 | 2026-03-13 | IRWD | DENNER ALEXANDER J | Dir | A - Grant | $0.00 | +4,451 | 256.3K | +2% | $0 | |
| 2026-03-12 | 2026-03-10 | IRWD | Martini Gregory S. | CFO | A - Grant | $0.00 | +136.6K | 297.2K | +85% | $0 | |
| 2026-03-12 | 2026-03-10 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +136.6K | 658.0K | +26% | $0 | |
| 2026-03-12 | 2026-03-10 | IRWD | Gaskins Tammi L | Chief Commercial Off | A - Grant | $0.00 | +136.6K | 350.4K | +64% | $0 | |
| 2026-03-12 | 2026-03-10 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +409.8K | 1.90M | +28% | $0 | |
| 2026-03-12 | 2026-03-10 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +163.9K | 416.6K | +65% | $0 | |
| 2026-03-12 | 2026-03-10 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +136.6K | 500.5K | +38% | $0 | |
| M | 2026-02-25 | 2026-02-23+ | IRWD | Gaskins Tammi L | Chief Commercial Off | S - Sale | $3.73 | -21.5K | 225.0K | -9% | -$80.3K |
| M | 2026-02-25 | 2026-02-23+ | IRWD | John Minardo | CLO | S - Sale | $3.73 | -36.5K | 382.9K | -9% | -$136.2K |
| M | 2026-02-25 | 2026-02-23+ | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $3.73 | -24.2K | 252.6K | -9% | -$90.2K |
| M | 2026-02-25 | 2026-02-23+ | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $3.73 | +1,442 | 521.4K | +0.3% | +$5,381 |
| M | 2026-02-25 | 2026-02-23+ | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $3.73 | -198.3K | 1.49M | -12% | -$739.9K |
| M | 2026-02-25 | 2026-02-23+ | IRWD | Martini Gregory S. | CFO | S - Sale | $3.73 | -21.9K | 172.1K | -11% | -$81.9K |
| T | 2026-01-07 | 2026-01-05 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $4.60 | -35.4K | 276.8K | -11% | -$162.9K |
| 2025-12-17 | 2025-12-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +4,178 | 251.9K | +2% | $0 | |
| 2025-11-19 | 2025-11-17 | IRWD | Gaskins Tammi L | Chief Commercial Off | S - Sale | $3.32 | -6,016 | 235.3K | -2% | -$20.0K | |
| 2025-09-17 | 2025-09-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +11.7K | 247.7K | +5% | $0 | |
| 2025-08-13 | 2025-08-11 | IRWD | Martini Gregory S. | CFO | S - Sale | $0.84 | -1,265 | 182.5K | -0.7% | -$1,063 | |
| 2025-08-13 | 2025-08-11 | IRWD | Gaskins Tammi L | Chief Commercial Off | S - Sale | $0.84 | -1,316 | 241.3K | -0.5% | -$1,105 | |
| 2025-08-13 | 2025-08-11 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $0.84 | -2,846 | 276.8K | -1% | -$2,391 | |
| 2025-08-13 | 2025-08-11 | IRWD | John Minardo | CLO | S - Sale | $0.84 | -7,754 | 400.4K | -2% | -$6,513 | |
| 2025-06-17 | 2025-06-13 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +24.2K | 236.0K | +11% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | Kessler Marla L | Dir | A - Grant | $0.00 | +45.0K | 165.9K | +37% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | Shepard Jay | Dir | A - Grant | $0.00 | +45.0K | 171.6K | +36% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | Duane Jon R | Dir | A - Grant | $0.00 | +45.0K | 190.3K | +31% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +45.0K | 211.8K | +27% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +45.0K | 228.3K | +25% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | Currie Mark G | Dir | A - Grant | $0.00 | +45.0K | 613.4K | +8% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +45.0K | 117.9K | +62% | $0 | |
| 2025-06-12 | 2025-06-10 | IRWD | McHugh Julie | Dir | A - Grant | $0.00 | +45.0K | 208.8K | +27% | $0 | |
| 2025-05-20 | 2025-05-20 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +540.0K | 1.69M | +47% | $0 | |
| 2025-05-20 | 2025-05-16 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $0.58 | -13.4K | 1.15M | -1% | -$7,745 | |
| 2025-05-20 | 2025-05-16 | IRWD | Gaskins Tammi L | Chief Commercial Off | S - Sale | $0.58 | -2,563 | 242.6K | -1% | -$1,487 | |
| 2025-04-04 | 2025-04-02 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +10.4K | 166.8K | +7% | $0 | |
| 2025-02-12 | 2025-02-10 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $1.76 | -139.1K | 1.16M | -11% | -$244.8K | |
| 2025-02-12 | 2025-02-10 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +133.3K | 595.3K | +29% | $0 | |
| 2025-02-12 | 2025-02-10 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $1.76 | -41.3K | 554.0K | -7% | -$72.6K | |
| 2025-02-12 | 2025-02-10 | IRWD | Martini Gregory S. | CFO | S - Sale | $1.76 | -12.1K | 183.8K | -6% | -$21.2K | |
| 2025-02-12 | 2025-02-10 | IRWD | John Minardo | CLO | S - Sale | $1.76 | -38.9K | 408.1K | -9% | -$68.5K | |
| 2025-02-12 | 2025-02-10 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +122.2K | 447.1K | +38% | $0 | |
| 2025-02-12 | 2025-02-10 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $1.76 | -12.0K | 279.7K | -4% | -$21.2K | |
| 2025-01-29 | 2025-01-27 | IRWD | Martini Gregory S. | CFO | A - Grant | $0.00 | +111.1K | 195.9K | +131% | $0 | |
| 2025-01-29 | 2025-01-27 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +133.3K | 291.7K | +84% | $0 | |
| 2025-01-22 | 2025-01-17 | IRWD | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +48.2K | 461.9K | +12% | $0 | |
| 2025-01-22 | 2025-01-17 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +147.4K | 1.30M | +13% | $0 | |
| 2025-01-22 | 2025-01-17 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +40.2K | 324.8K | +14% | $0 | |
| 2024-12-18 | 2024-12-16 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +4,249 | 156.4K | +3% | $0 | |
| 2024-11-20 | 2024-11-18 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $4.08 | -5,360 | 284.7K | -2% | -$21.9K | |
| 2024-11-20 | 2024-11-18 | IRWD | Emany Sravan Kumar | SVP, COO, CFO | S - Sale | $4.08 | -11.0K | 309.6K | -3% | -$44.9K | |
| 2024-09-18 | 2024-09-16 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +3,282 | 152.1K | +2% | $0 | |
| 2024-08-14 | 2024-08-12 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $4.27 | -3,107 | 158.4K | -2% | -$13.3K | |
| 2024-08-14 | 2024-08-12 | IRWD | John Minardo | CLO | S - Sale | $4.27 | -9,910 | 284.7K | -3% | -$42.3K | |
| 2024-06-21 | 2024-06-18 | IRWD | Dreyfus Andrew | Dir | A - Grant | $0.00 | +24.3K | 188.2K | +15% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | McHugh Julie | Dir | A - Grant | $0.00 | +24.3K | 163.8K | +17% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | Duane Jon R | Dir | A - Grant | $0.00 | +24.3K | 145.3K | +20% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +24.3K | 148.8K | +20% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | Moukheibir Catherine | Dir | A - Grant | $0.00 | +24.3K | 72.9K | +50% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | Kessler Marla L | Dir | A - Grant | $0.00 | +24.3K | 120.9K | +25% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | Currie Mark G | Dir | A - Grant | $0.00 | +24.3K | 568.4K | +4% | $0 | |
| 2024-06-21 | 2024-06-18 | IRWD | Shepard Jay | Dir | A - Grant | $0.00 | +24.3K | 126.6K | +24% | $0 | |
| 2024-06-18 | 2024-06-15 | IRWD | Sarissa Capital Management LP | 10% | A - Grant | $0.00 | +2,572 | 124.5K | +2% | $0 | |
| T | 2024-06-12 | 2024-06-10 | IRWD | McHugh Julie | Dir | S - Sale | $6.29 | -22.8K | 139.5K | -14% | -$143.2K |
| M | 2024-06-10 | 2024-06-06+ | IRWD | Moukheibir Catherine | Dir | S - Sale | $6.47 | -80.0K | 48.6K | -62% | -$517.7K |
| 2024-05-22 | 2024-05-20 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $6.45 | -67.6K | 1.15M | -6% | -$436.1K | |
| 2024-05-22 | 2024-05-20 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $6.45 | -16.1K | 413.7K | -4% | -$104.0K | |
| 2024-05-22 | 2024-05-20 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $6.45 | -22.7K | 288.0K | -7% | -$146.6K | |
| 2024-05-22 | 2024-05-20 | IRWD | John Minardo | CLO | S - Sale | $6.45 | -17.4K | 294.6K | -6% | -$112.3K | |
| 2024-05-20 | 2024-05-16 | IRWD | Emany Sravan Kumar | SVP, CFO | F - Tax | $6.64 | -18.3K | 320.6K | -5% | -$121.4K | |
| 2024-03-19 | 2024-03-15 | IRWD | DENNER ALEXANDER J | Dir, 10% | A - Grant | $0.00 | +1,662 | 121.9K | +1% | $0 | |
| D | 2024-03-12 | 2024-03-08 | IRWD | Davis Andrew | SVP, Chief Business Off | M - OptEx | $0.00 | +37.1K | 310.8K | +14% | $0 |
| D | 2024-03-12 | 2024-03-08 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | M - OptEx | $0.00 | +34.9K | 429.8K | +9% | $0 |
| D | 2024-03-12 | 2024-03-08 | IRWD | John Minardo | CLO | M - OptEx | $0.00 | +32.8K | 312.0K | +12% | $0 |
| D | 2024-03-12 | 2024-03-08 | IRWD | Emany Sravan Kumar | SVP, CFO | M - OptEx | $0.00 | +37.1K | 338.9K | +12% | $0 |
| D | 2024-03-12 | 2024-03-08 | IRWD | MCCOURT Thomas A | CEO, Dir | M - OptEx | $0.00 | +120.3K | 1.22M | +11% | $0 |
| 2024-03-08 | 2024-03-06 | IRWD | Duane Jon R | Dir | P - Purchase | $8.70 | +6,920 | 121.0K | +6% | +$60.2K | |
| D | 2024-03-07 | 2024-03-05 | IRWD | MCCOURT Thomas A | CEO, Dir | A - Grant | $0.00 | +264.9K | 1.10M | +32% | $0 |
| 2024-03-06 | 2024-03-04 | IRWD | Emany Sravan Kumar | SVP, CFO | P - Purchase | $9.38 | +10.7K | 301.7K | +4% | +$100.2K | |
| 2024-02-14 | 2024-02-12 | IRWD | Silver Ronald | Principal Accounting Off | A - Grant | $0.00 | +27.2K | 161.5K | +20% | $0 | |
| 2024-02-14 | 2024-02-12 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $15.24 | -7,908 | 134.3K | -6% | -$120.5K | |
| D | 2024-02-14 | 2024-02-12 | IRWD | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +65.3K | 291.0K | +29% | $0 |
| D | 2024-02-14 | 2024-02-12 | IRWD | John Minardo | CLO | S - Sale | $15.24 | -47.4K | 224.8K | -17% | -$722.1K |
| D | 2024-02-14 | 2024-02-12 | IRWD | John Minardo | CLO | A - Grant | $0.00 | +54.4K | 279.2K | +24% | $0 |
| D | 2024-02-14 | 2024-02-12 | IRWD | Davis Andrew | SVP, Chief Business Off | S - Sale | $15.24 | -9,846 | 208.3K | -5% | -$150.1K |
| D | 2024-02-14 | 2024-02-12 | IRWD | Davis Andrew | SVP, Chief Business Off | A - Grant | $0.00 | +65.3K | 273.6K | +31% | $0 |
| D | 2024-02-14 | 2024-02-12 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $15.24 | -38.6K | 340.5K | -10% | -$588.5K |
| D | 2024-02-14 | 2024-02-12 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +54.4K | 394.9K | +16% | $0 |
| 2024-02-14 | 2024-02-12 | IRWD | MCCOURT Thomas A | CEO, Dir | S - Sale | $15.24 | -177.2K | 832.8K | -18% | -$2.70M |
Purchase Sale Sale after option exercise All abbreviations